Skip to main content
. Author manuscript; available in PMC: 2012 Oct 29.
Published in final edited form as: Toxicol Pathol. 2010 Jan 15;38(1):88–95. doi: 10.1177/0192623309357074

Figure 2.

Figure 2

Use of genetically engineered mouse models to identify genetic pathways, drugable targets, and novel targets that are critical for tumor growth and survival. Mouse models are amenable to testing of targeted drug therapies and novel drug combinations, and understanding mechanisms of drug resistance that cannot be easily accomplished in clinical trials.